Please assess the completion status of the following clinical trial:

Trial Title: Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 18-65 years~* DSM-IV Criteria BD I or II depressive episode,~* SIGH-ADS \>20; duration \>2 weeks.~* Stable dose antidepressant drug \>8 weeks with concurrent antimanic drug~* Controlled thyroid disease~* Subjects with preexisting eye diseases will be included.~* Able to provide informed consent~* Stable minimum dose antimanic drug \>4weeks: lithium 0.5 mEq/L, divalproex Na 50 mcg/mL, olanzapine 5mg daily, carbamazepine 4mg/L; lamotrigine 100mg daily, risperidone 2mg daily, quetiapine 400 mg daily, ziprasidone 10 mg bid, and aripiprazole 5 mg qd.~* Stable unchanged psychotherapy for \>16weeks~Exclusion Criteria:~* The following eye diseases: retinal disease, cataract surgery and lens removal, macular degeneration,~* Taking photosensitizing drugs such as phenothiazines (chlorpromazine), antimalarial drugs, melatonin and hypericum.~* Acute psychosis (DSM-IV Criteria)~* Rapid cycling in the past 1 year~* Obsessive compulsive disorder~* Alcohol or substance abuse or dependence in the past 6 months.~* MRS\>5~* Recent history of a suicide attempt (3 months) or active suicidal Ideation (SIGHADS item H11 \>2)~* Beta-adrenergic blockers, exogenous melatonin, chronic NSAIDS

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Active Comparator (Type: ACTIVE_COMPARATOR): 7000lux broad-spectrum light
- Inactive Comparator (Type: PLACEBO_COMPARATOR): 50lux dim red light

Based on this trial design, predict the completion outcome and termination type (if applicable).